In 2024, Rostec-affiliated enterprises supplied approximately 85,000 units of medical equipment to healthcare institutions across the country. This was announced by the corporation's CEO, Sergey Chemezov, at a meeting with Prime Minister Mikhail Mishustin.
Currently, Rostec's product portfolio includes over 150 registered medical devices. The plan is to quadruple the state corporation's presence in this market.
We intend to launch mass production of about 40 new types of high-tech equipment.
Among the new developments is the OneCell Scan 3.0 software and hardware complex. It is designed for the diagnosis of oncological diseases using artificial intelligence (AI). Currently, up to 25 devices are produced per year, and the production volume will be increased to 200 units.
In Zelenograd, the production of a continuous glucose monitoring system for patients with diabetes is being established. This is a small sticker that is attached to the shoulder and transmits information about blood sugar levels to a smartphone.
Read more on the topic:
T-lymphocytes Trained to Fight Cancer in "Sirius"
The First Russian Biosimilar of a Breast Cancer Drug Was Approved by the Ministry of Health